APC 2026 Agenda
Thursday April 2, 2026 |
||||
| Updated 2/9/2026 *Speakers and titles are subject to change | ||||
| Session | Speaker | Company | Time | |
| Registration and Coffee | 7:45AM-8:45AM | |||
| Conference Opening | Catherine Lebrun | Nexo Therapeutics | 8:45AM - 8:55AM | |
| Speaker Introduction | Cheng Zhong | Sai Life Sciences | 8:55AM-9:00AM | |
|
Chemomics Applied: What Leveraging a Complete DEL Dataset Looks Like in Practice |
Rebecca Swett | X-Chem | 9:00AM-9:30AM | |
| Speaker Introduction | Christopher Reimann | AstraZeneca | 9:30AM-9:35AM | |
| Accelerated Discovery of a Carbamate Scaffold Cbl-b Inhibitor Using Generative Models and Structure-Based Drug Design | Taylor Quinn | AstraZeneca | 9:35AM-10:05AM | |
| Speaker Introduction | Mitchell Keylor | Merck | 10:05AM-10:10AM | |
| Design and Synthesis of BLU-654, a Potent and Selective Mutant KIT V654A Inhibitor for the Treatment of Imatinib-resistant GIST | Ludivine Moine | Blueprint Medicines | 10:10AM-10:40AM | |
| AM Break | 10:40AM-11:00AM | |||
| Speaker Introduction | Rebecca Casaubon | Triana Biomedicines | 11:00AM-11:05AM | |
| Discovery and Optimization of a Novel Covalent WRN Helicase Inhibitor Series | Momar Toure | Moma Therapeutics | 11:05AM-11:35AM | |
| Speaker Introduction | Benoit Moreau | MapleSeed | 11:35AM-11:40AM | |
| UM171: From Stem Cell Expansion to CoREST Degradation—A Clinical Molecular Glue Story | Anne Marinier | University of Montreal | 11:40AM-12:10PM | |
| Speaker Introduction | Catherine Lebrun | Nexo Therapeutics | 12:10PM-12:15PM | |
|
Plenary Lecture The Radicalization of Drug Discovery |
Greg Verdine | LifeMine Therapeutics | 12:15PM-12:56PM | |
| Lunch | 12:55PM-2:10PM | |||
| Speaker Introduction | David Ebner | Pfizer | 2:10PM-2:15PM | |
| Vendor Talk - From Computer Aided to Computer Accelerated Drug Discovery | Abba Leffler |  |
2:15PM-2:40PM | |
| Speaker Introduction | Michael Schultz | Novartis | 2:40PM-2:45PM | |
| IL4i1 Inhibitors from Target Validation Through to First-In-Human Studies in Cancer Patients | Elsie Yu | Merck | 2:45PM-3:15PM | |
| Speaker Introduction | Susan Ashwell | Sashchem Consulting | 3:15PM-3:20PM | |
| Discovery of a DLL3-targeting Macrocyclic Peptide Radioligand Therapy for the Treatment of SCLC | Murray Wan | Mariana Oncology | 3:20PM-3:50PM | |
| PM Break | 3:50PM-4:10PM | |||
| Speaker Introduction | Shashank Kulkarni | Nuvalent | 4:10PM-4:15PM | |
|
Plenary Lecture Structure Prediction of Cyclic Peptides via Molecular Dynamics and Machine Learning |
Yu-Shan Lin | Tufts University | 4:15PM-4:55PM | |
| Closing Remarks | Cheng Zhong | Sai Life Sciences | 4:55PM-5:00PM | |
| Reception | 5:00PM-6:00PM | |||